World's Best Scientists 2026 revealed!
Paolo Gionchetti

Paolo Gionchetti

D-Index & Metrics

Medicine

D-Index
85
Citations
37584
World Ranking
14399
National Ranking
551

Paolo Gionchetti publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Paolo Gionchetti sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 459 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Paolo Gionchetti D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Paolo Gionchetti sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Paolo Gionchetti is affiliated with the University of Bologna in Italy and has a substantial publication record in the field of medicine, with a focus on gastroenterology and associated disorders. Their research spans various domains within medicine and biochemistry, genetics, and molecular biology.

Their work prominently addresses inflammatory bowel disease and related gastrointestinal conditions, with significant contributions to treatment guidelines and clinical studies.

Recent notable publications include:

  • ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment, 2021, Journal of Crohn's and Colitis
  • ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment, 2021, Journal of Crohn's and Colitis
  • Vedolizumab for the Treatment of Chronic Pouchitis, 2023, New England Journal of Medicine
  • Etrolizumab versus infliximab for the treatment of moderately to severely active ulcerative colitis (GARDENIA): a randomised, double-blind, double-dummy, phase 3 study, 2021, The Lancet. Gastroenterology & Hepatology
  • Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study, 2023, Gastroenterology

Research collaborations are frequent with co-authors such as:

  • Fernando Rizzello
  • Carlo Calabrese
  • Nikolas Dussias
  • Marco Salice
  • Gilberto Poggioli

Gionchetti's publications appear predominantly in the following venues:

  • Journal of Crohn's and Colitis (27 publications)
  • Digestive and Liver Disease (15 publications)
  • Gastroenterology (10 publications)
  • Inflammatory Bowel Diseases (5 publications)
  • Alimentary Pharmacology & Therapeutics (2 publications)

The main fields of study covered by Paolo Gionchetti include Medicine and Biochemistry, Genetics and Molecular Biology, with specialized subfields such as Genetics, Surgery, Epidemiology, Gastroenterology, and Oncology. The principal topics addressed in their research are:

  • Inflammatory Bowel Disease
  • Microscopic Colitis
  • Diverticular Disease and Complications
  • Eosinophilic Esophagitis
  • Gastrointestinal Disorders and Treatments
  • Immunodeficiency and Autoimmune Disorders
  • Colorectal Cancer Surgical Treatments

Best Publications

  • 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

    Fernando Gomollón;Axel Dignass;Vito Annese;Herbert Tilg

  • Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

    Paolo Gionchetti;Fernando Rizzello;Alessandro Venturi;Patrizia Brigidi

  • Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders.

    Fernando Magro;Paolo Gionchetti;Rami Eliakim;Sandro Ardizzone

  • Prophylaxis of pouchitis onset with probiotic therapy: A double-blind, placebo-controlled trial

    Paolo Gionchetti;Fernando Rizzello;Ulf Helwig;Alessandro Venturi

  • The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

    Gert Van Assche;Axel Dignass;Walter Reinisch;C. Janneke van der Woude

  • Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

    T Mimura;Fernando Rizzello;U Helwig;Gilberto Poggioli

  • ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment

    Joana Torres;Stefanos Bonovas;Glen Doherty;Torsten Kucharzik

  • VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

    Rodrigo Bibiloni;Richard N Fedorak;Gerald W Tannock;Karen L Madsen

  • European evidence based consensus on the diagnosis and management of Crohn’s disease: current management

    Spl Travis;EF Stange;Marc Lémann;T Oresland

  • 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

    Paolo Gionchetti;Axel Dignass;Silvio Danese;Fernando José Magro Dias

  • Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis

    A Venturi;P Gionchetti;F Rizzello;R Johansson

  • Modulation of human dendritic cell phenotype and function by probiotic bacteria

    A. L. Hart;K. M. Lammers;Patrizia Brigidi;Beatrice Vitali

  • Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations

    Gert Van Assche;Axel Dignass;Bernd Bokemeyer;Silvio Danese

  • Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production.

    Marco Candela;Federico Perna;P. Carnevali;Beatrice Vitali

  • Immunomodulatory effects of probiotic bacteria DNA: IL-1 and IL-10 response in human peripheral blood mononuclear cells.

    Karen Manon Lammers;Patrizia Brigidi;Beatrice Vitali;Paolo Gionchetti

  • ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

    Antonino Spinelli;Stefanos Bonovas;Johan Burisch;Torsten Kucharzik

  • European evidence based consensus on surgery for ulcerative colitis.

    Tom Øresland;Willem A. Bemelman;Gianluca M. Sampietro;Antonino Spinelli

  • Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease.

    Mario Cottone;Anna Kohn;Marco Daperno;Alessandro Armuzzi

  • Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis

    Mariagrazia Uguccioni;Paolo Gionchetti;Davide F. Robbiani;Fernando Rizzello

  • Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

    Miguel Regueiro;Brian G. Feagan;Bin Zou;Jewel Johanns

Frequent Co-Authors

Massimo Campieri
Massimo Campieri University of Bologna
Luigi Barbara
Luigi Barbara University of Bologna
Silvio Danese
Silvio Danese Vita-Salute San Raffaele University
Patrizia Brigidi
Patrizia Brigidi University of Bologna
Vito Annese
Vito Annese Casa Sollievo della Sofferenza
Simon Travis
Simon Travis University of Oxford
Stefan Schreiber
Stefan Schreiber Kiel University
Michael A. Kamm
Michael A. Kamm University of Melbourne
Julián Panés
Julián Panés University of Barcelona
Carlo Salvarani
Carlo Salvarani University of Modena and Reggio Emilia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a traditional medical degree in the USA requires a significant commitment of time and resources. For those seeking alternative routes into healthcare, a range of related online degrees and certifications can open up rewarding career pathways.

Entry-level options include taking medical billing and coding classes online, which prepare students for vital behind-the-scenes roles in healthcare administration. For those aiming to provide direct patient care, there are affordable nursing programs online, offering flexibility and accessibility for aspiring nurses.

Experienced nurses can further their qualifications through most affordable online nurse practitioner programs. These advanced degrees can lead to greater responsibility, autonomy, and salary potential within the healthcare system. Ambitious nursing professionals can also consider an online nursing doctorate, which opens doors to leadership, teaching, and high-level research positions.

Exploring these online programs can provide flexibility, cost savings, and a pathway into a range of in-demand healthcare careers, even if becoming a physician isn't the right fit.

Best Scientists Citing Paolo Gionchetti

Trending Scientists

Recently Published Articles